Ani Pharmaceuticals reported $17.18M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Aerie Pharmaceuticals AERI:US $ 34.66M 114K
Ani Pharmaceuticals ANIP:US $ 17.18M 1.64M
Aurora Cannabis Inc ACB:CN 48.61M 210K
Biodelivery Sciences International BDSI:US $ 25.47M 311K
Canopy Growth Corp WEED:CN C$ 141.71M 30.66M
Depomed DEPO:US $ 9.31M 16.92M
Eli Lilly And LLY:US $ 1.58B 107.8M
Emergent Biosolutions EBS:US $ 82.1M 9.1M
Endo International Ordinary Shares ENDP:US 241.92M 70.98M
Flexion Therapeutics FLXN:US $ 26.99M 423K
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Hikma Pharmaceutical HIK:LN 232M 3M
Knight Therapeutics Inc GUD:CN C$ 18.75M 118K
Lannett LCI:US $ 18.9M 2.67M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Novartis NVS:US 3.6B 109M
Omeros OMER:US $ 20.86M 699K
Perrigo Ordinary Shares PRGO:US 283.6M 11.7M
Sun Pharmaceuticals SUNP:IN 18.06B 475.3M
Teva Pharmaceutical TEVA:IT 864M 32M
Teva Pharmaceutical Industries TEVA:US 864M 32M